Publications by authors named "Vincent Bize"

Claim this Profile
F
First-in human, phase 1, dose-escalation pharmacokinetic and pharmacodynamic study of the oral dual PI3K and mTORC1/2 inhibitor PQR309 in patients with advanced solid tumors (SAKK 67/13).
Andreas Wicki, Nicholas Brown, Alexandros Xyrafas, Vincent Bize, Hanne Hawle

Eur J Cancer· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10).
Bernhard C Pestalozzi, Christoph Tausch, Konstantin J Dedes, Christoph Rochlitz, Stefan Zimmermann, Vincent Bize

BMC Cancer· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nephron-Specific Deletion of Circadian Clock Gene Bmal1 Alters the Plasma and Renal Metabolome and Impairs Drug Disposition.
Svetlana Nikolaeva, Camille Ansermet, Gabriel Centeno, Sylvain Pradervand, Vincent Bize

J Am Soc Nephrol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sodium self-inhibition of human epithelial sodium channel: selectivity and affinity of the extracellular sodium sensing site.
Vincent Bize, Jean-Daniel Horisberger

Am J Physiol Renal Physiol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis